3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
2
Breast Neoplasms
2
Vascular Diseases
1
Rectal Neoplasms
1
Precancerous Conditions
1
Neurotoxicity Syndromes
1
Myocardial Ischemia
1
Myocardial Infarction
1
Heart Diseases
1
Fibrosis
1
Fatigue
1
Erectile Dysfunction
1
Coronary Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cerebrovascular Disorders
1
Cardiovascular Diseases
1
Brain Neoplasms
1
Adenomatous Polyps
1
Interventions
Gemcitabine
47
Cisplatin
32
pembrolizumab
28
Paclitaxel
13
Docetaxel
13
avelumab
12
Mitomycin
12
atezolizumab
11
Nivolumab
11
Cystectomy
10
Carboplatin
9
durvalumab
7
Sunitinib
7
apaziquone
6
Doxorubicin
6
BCG Vaccine
6
5-aminolevulinic acid hexyl ester
6
Vinblastine
5
Radiation
5
Platinum
5
Methotrexate
5
Magnetic Resonance Spectroscopy
5
Albumin-Bound Paclitaxel
5
Taxes
4
Standard of Care
4
Sorafenib
4
Radiotherapy
4
Fluorouracil
4
Erlotinib Hydrochloride
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urinary Bladder Neoplasms
×
Vitamin E
×
Clear all
No trials found.